Small but focused PONTiS Orthopaedics is a small medical device company (2-10 employees) focused on upper and lower extremity bone and soft tissue repair, presenting an opportunity to engage early with decision makers in product development, regulatory strategy, and clinical adoption.

FDA approval milestone They have achieved FDA approval for the PONTiS Flexor Tendon Repair System and are advancing clinical use, signaling a potential sales window for expanding procedural adoption, training, and related instrumentation across surgical centers.

Product expansion potential Current product focus on tendon and ligament repair suggests opportunities to upsell complementary implants, instrumentation, and training services as surgeons expand indications or adopt integrated repair workflows.

Revenue growth opportunity With revenues below one million, there is room for rapid growth through strategic partnerships, distributor networks, and targeted market development in orthopedics and hand surgery to accelerate sales velocity.

Competitive landscape fit Positioning relative to mid-scale players with substantial sales forces (e.g., Globus, Biosense Webster) indicates a need for nimble, relationship-driven sales strategies, focused clinical evidence pitches, and early adopter programs to establish market traction.